Reuters logo
BRIEF-Bayer gets positive CHMP opinion to update rivaroxaban's label
September 15, 2017 / 12:07 PM / 11 days ago

BRIEF-Bayer gets positive CHMP opinion to update rivaroxaban's label

Sept 15 (Reuters) - BAYER AG:

* RECEIVES POSITIVE CHMP OPINION FOR RIVAROXABAN 10 MG ONCE DAILY FOR EXTENDED PREVENTION OF VENOUS THROMBOEMBOLISM

* ‍FINAL EUROPEAN COMMISSION DECISION EXPECTED BY NOVEMBER 2017​ Source text - bit.ly/2x6O0Vm Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below